Mark Sullivan, MD, PhD

Personal Statement

My clinical service and research focuses on the interaction of mental and physical illness, especially in patients with chronic pain or heart disease. Much of my research in the past decade has focused on the risks of treating chronic pain with opioids. I have developed educational programs and outcome tracking tools to assist with opioid treatment of chronic pain. I am interested in expanding the role for the patient in the care of chronic illness and am completing a book on this topic.​

Education

Vanderbilt Univ. Sch. of Medicine Medical education, 1984
Univ. of Missouri Columbia Internship, Family Medicine
UW - Dept. of Psychiatry & Behavioral Sciences Residency, Psychiatry

Department Affiliations

Teaching Philosophy

​I like to have trainees manage patients under my supervision. Trainees need real responsibility to learn and develop management skills.
In didactic sessions, I strive for interaction between myself and trainees. I generally teach in a seminar format centered around case presentations. I expect all trainees to contribute to the discussion and the learning of others.

Recent Publications

Hybrid Aptamer-Molecularly Imprinted Polymer (aptaMIP) Nanoparticles from Protein Recognition-A Trypsin Model.
(2021 Mar 24)
Macromol Biosci
Sullivan MV, Clay O, Moazami MP, Watts JK, Turner NW

The protocol of the Application of Economics & Social psychology to improve Opioid Prescribing Safety Trial 1 (AESOPS-1): Electronic health record nudges.
(2021 Feb 24)
Contemp Clin Trials 103(): 106329
Kelley MA, Persell SD, Linder JA, Friedberg MW, Meeker D, Fox CR, Goldstein NJ, Knight TK, Zein D, Rowe TA, Sullivan MD, Doctor JN

"We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering Program.
(2021 Feb 22)
Pain Med
Firemark AJ, Schneider JL, Kuntz JL, Papajorgji-Taylor D, Dickerson JF, Thorsness LA, Reese KR, Sullivan MD, Debar LL, Smith DH

A strategic approach to improving pharmacy enterprise automation: Development and initial application of the Autonomous Pharmacy Framework.
(2021 Mar 18)
Am J Health Syst Pharm 78(7): 636-645
Flynn AJ, Fortier C, Maehlen H, Pierzinski V, Runnebaum R, Sullivan M, Wagner J, Stevenson JG

The association between self-perceived walking pace with the incidence of hypertension: the 'Seguimiento Universidad de Navarra' cohort.
(2021 Feb 3)
J Hypertens
Etzig C, Gea A, Martínez-González MÁ, Sullivan MF Jr, Sullivan E, Bes-Rastrollo M

Show complete publication list »
Edit Profile